Kyle T. Greenway

795 total citations
36 papers, 408 citations indexed

About

Kyle T. Greenway is a scholar working on Clinical Psychology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Kyle T. Greenway has authored 36 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Psychology, 11 papers in Pharmacology and 10 papers in Organic Chemistry. Recurrent topics in Kyle T. Greenway's work include Psychedelics and Drug Studies (15 papers), Treatment of Major Depression (10 papers) and Chemical synthesis and alkaloids (9 papers). Kyle T. Greenway is often cited by papers focused on Psychedelics and Drug Studies (15 papers), Treatment of Major Depression (10 papers) and Chemical synthesis and alkaloids (9 papers). Kyle T. Greenway collaborates with scholars based in Canada, United States and United Kingdom. Kyle T. Greenway's co-authors include Nicolas Garel, Stéphane Richard‐Devantoy, Allison A. Feduccia, Lisa Jerome, Soham Rej, B. Mario Pinto, Gustavo Turecki, Harmehr Sekhon, Eric B. LeGresley and Bernardine M. Pinto and has published in prestigious journals such as PLoS ONE, Scientific Reports and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Kyle T. Greenway

34 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle T. Greenway Canada 12 209 108 77 76 57 36 408
Oskar Hougaard Jefsen Denmark 10 219 1.0× 81 0.8× 53 0.7× 61 0.8× 98 1.7× 20 434
Cale Basaraba United States 12 162 0.8× 43 0.4× 177 2.3× 90 1.2× 111 1.9× 37 488
Enrique López United States 12 255 1.2× 49 0.5× 106 1.4× 32 0.4× 99 1.7× 33 470
Piotr Gorczyca Poland 13 171 0.8× 20 0.2× 49 0.6× 100 1.3× 37 0.6× 97 587
Emma Morton Canada 14 141 0.7× 40 0.4× 46 0.6× 232 3.1× 28 0.5× 47 489
Dimitri Daldegan‐Bueno Brazil 12 185 0.9× 59 0.5× 139 1.8× 22 0.3× 67 1.2× 34 359
Udo Schneider Germany 5 304 1.5× 179 1.7× 56 0.7× 33 0.4× 168 2.9× 8 404
Hugh Claridge United Kingdom 13 127 0.6× 46 0.4× 92 1.2× 19 0.3× 82 1.4× 20 457
Justin Sinclair Australia 15 194 0.9× 63 0.6× 381 4.9× 51 0.7× 105 1.8× 33 916
Ashley Siegel Canada 10 167 0.8× 34 0.3× 99 1.3× 48 0.6× 39 0.7× 17 378

Countries citing papers authored by Kyle T. Greenway

Since Specialization
Citations

This map shows the geographic impact of Kyle T. Greenway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle T. Greenway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle T. Greenway more than expected).

Fields of papers citing papers by Kyle T. Greenway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle T. Greenway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle T. Greenway. The network helps show where Kyle T. Greenway may publish in the future.

Co-authorship network of co-authors of Kyle T. Greenway

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle T. Greenway. A scholar is included among the top collaborators of Kyle T. Greenway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle T. Greenway. Kyle T. Greenway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salle, Sara de la, et al.. (2025). The ketamine chameleon: history, pharmacology, and the contested value of experience. Expert Review of Clinical Pharmacology. 18(3). 109–129. 1 indexed citations
2.
3.
Garel, Nicolas, et al.. (2025). The promise and challenges of psychedelic-assisted therapy: lessons from Canada’s Special Access Program. Nature Mental Health. 3(7). 756–759.
4.
Greenway, Kyle T., Nicolas Garel, Lê-Anh Dinh-Williams, et al.. (2025). The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression. The British Journal of Psychiatry. 1–9. 1 indexed citations
5.
Moses, Lincoln E., et al.. (2025). A systematic review of hyperscanning in clinical encounters. Neuroscience & Biobehavioral Reviews. 176. 106248–106248. 1 indexed citations
6.
Erritzøe, David, et al.. (2024). Psychedelics and the ‘inner healer’: Myth or mechanism?. Journal of Psychopharmacology. 38(5). 417–424. 9 indexed citations
7.
Greenway, Kyle T., Nicolas Garel, Lê-Anh Dinh-Williams, et al.. (2024). Music as an Intervention to Improve the Hemodynamic Response of Ketamine in Depression. JAMA Network Open. 7(2). e2354719–e2354719. 4 indexed citations
8.
9.
10.
Brouillette, Marie‐Josée, et al.. (2024). Rapid Improvement of Post-Partum Depression With Subanesthetic Racemic Ketamine. Journal of Clinical Psychopharmacology. 44(2). 196–198. 1 indexed citations
11.
Garel, Nicolas, Kyle T. Greenway, Lê-Anh Dinh-Williams, et al.. (2023). Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report. Neuropsychopharmacology. 48(12). 1769–1777. 5 indexed citations
12.
Garel, Nicolas, Nathalie Goyette, Alexandre Lehmann, et al.. (2023). The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression. Frontiers in Psychiatry. 14. 1268832–1268832. 13 indexed citations
13.
Sekhon, Harmehr, et al.. (2022). Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research. CNS Drugs. 36(10). 1049–1077. 19 indexed citations
14.
Gobbi, Gabriella, Antonio Inserra, Kyle T. Greenway, Michael Lifshitz, & Laurence J. Kirmayer. (2022). Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Transcultural Psychiatry. 59(5). 718–724. 5 indexed citations
15.
Duarte, Dante, Raoul Belzeaux, Bruno Étain, et al.. (2020). Childhood-maltreatment subtypes in bipolar patients with suicidal behavior: systematic review and meta-analysis. Brazilian Journal of Psychiatry. 42(5). 558–567. 17 indexed citations
16.
Richard‐Devantoy, Stéphane, Josie‐Anne Bertrand, Séverine Béziat, et al.. (2020). Psychological pain and depression: it’s hard to speak when it hurts. International Journal of Psychiatry in Clinical Practice. 25(2). 180–186. 12 indexed citations
17.
Greenway, Kyle T., Nicolas Garel, Lisa Jerome, & Allison A. Feduccia. (2020). Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology. 13(6). 655–670. 59 indexed citations
18.
MacMillan, Erin L., et al.. (2019). Longer Repetition Time Proton MR Spectroscopy Shows Increasing Hippocampal and Parahippocampal Metabolite Concentrations with Aging. Journal of Neuroimaging. 29(5). 592–597. 8 indexed citations
19.
Richard‐Devantoy, Stéphane, Massimiliano Orri, Josie‐Anne Bertrand, et al.. (2019). Childhood cognitive skill trajectories and suicide by mid-adulthood: an investigation of the 1958 British Birth Cohort. Psychological Medicine. 51(3). 400–407. 8 indexed citations
20.
Greenway, Kyle T., et al.. (2008). Experimental and theoretical study of the reaction of 2-methyl-3-buten-2-ol with Mu. Physica B Condensed Matter. 404(5-7). 943–945. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oskar Hougaard Jefsen Breakdown of academic impact, for papers by Cale Basaraba Breakdown of academic impact, for papers by Enrique López Breakdown of academic impact, for papers by Piotr Gorczyca Breakdown of academic impact, for papers by Emma Morton Breakdown of academic impact, for papers by Dimitri Daldegan‐Bueno Breakdown of academic impact, for papers by Udo Schneider Breakdown of academic impact, for papers by Hugh Claridge Breakdown of academic impact, for papers by Justin Sinclair Breakdown of academic impact, for papers by Ashley Siegel
Rankless by CCL
2026